Log In
Print this Print this

Ad5.hAC6 (RT-100)

  Manage Alerts
Collapse Summary General Information
Company Renova Therapeutics
DescriptionGene therapy comprised of intracoronary delivery of adenovirus 5 (Ad5) encoding adenylate cyclase 6 (ADCY6; AC6)
Molecular Target
Mechanism of Action 
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPhase II
Standard IndicationCongestive heart failure (CHF)
Indication DetailsTreat congestive heart failure (CHF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today